Finnish translation, validation, and reproducibility of BREAST-Q modules relevant to breast cancer treatment

被引:0
|
作者
Homsy, Pauliina [1 ,2 ]
Repo, Jussi [3 ,4 ]
Kuhlefelt, Charlotta [1 ,2 ,5 ]
Lindford, Andrew [1 ,2 ]
Ihalainen, Hanna
Kauhanen, Susanna [2 ,6 ,7 ]
Jahkola, Tiina [1 ,2 ]
机构
[1] Univ Helsinki, Dept Plast Surg, Pistosairaala,POB 28100029, Helsinki, Finland
[2] Helsinki Univ Hosp, Pistosairaala,POB 4281, Helsinki, Finland
[3] Tampere Univ Hosp, Dept Orthoped & Traumatol, Tampere, Finland
[4] Univ Tampere, Tampere, Finland
[5] Lahti Cent Hosp, Dept Surg, Paijat Hame Joint Author Hlth & Wellbeing, Lahti, Finland
[6] Helsinki Univ Hosp, Comprehens Canc Ctr, Breast Surg Unit, Helsinki, Finland
[7] Akadem Sjukhuset, Dept Maxillofacial & Plast Surg, Uppsala, Sweden
关键词
BREAST-Q; breast cancer; patient-reported outcomes; health-related quality of life; breast surgery; REPORTED OUTCOME MEASURES; QUALITY-OF-LIFE; SURGERY;
D O I
10.1177/14574969241277636
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background and objective: Breast cancer and its treatments can have a marked impact on the patient health-related quality of life. The aim of this study was to produce and validate Finnish versions of the breast-conserving treatment, mastectomy and breast reconstruction modules of the BREAST-Q, a patient-reported outcome tool designed specifically for women undergoing treatment for breast cancer. Methods: The relevant BREAST-Q modules were translated to Finnish according to established guidelines. Altogether 777 preoperative women were recruited at the Breast Surgery Unit and the Plastic Surgery Unit of Helsinki University Hospital between December 2019 and March 2021. This included 541 patients scheduled for breast-conserving surgery, 86 for mastectomy, and 150 for breast reconstruction. Postoperative patients were recruited through a postal survey, approaching 500 women operated for breast cancer in 2017, including 250 women who had undergone breast-conserving surgery and 250 women who had undergone mastectomy, as well as 339 women who had undergone breast reconstruction between August 2017 and July 2019. The patients were invited to fill the BREAST-Q modules relevant to their treatment and the general health-related quality-of-life instrument SF-36. A repeat administration of the BREAST-Q was done 2 weeks later. Results: A total of 665 (41%) women participated in the study, 339 (44%) preoperatively and 326 (39%) postoperatively. The BREAST-Q subscales showed high internal consistency with most Cronbach's alphas > 0.8. The repeatability of the subscales was excellent with most intra-class correlation coefficients > 0.75. Low or negligible correlation was observed between BREAST-Q subscales and SF-36 domains. Conclusions: The Finnish version of the BREAST-Q modules breast-conserving treatment, mastectomy, and breast reconstruction performs well in assessing the health-related quality of life of women undergoing surgery for breast cancer or breast reconstruction.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] The BREAST-Q: Translation and validation for Mexican population
    Bargallo-Rocha, J.
    Gutierrez-Zacarias, L.
    Gallargo-Alvarado, L.
    Maciel-Miranda, J.
    Shaw-Dulin, R.
    Esparza-Arias, N.
    Figueroa-Padilla, J.
    Vazquez-Romo, R.
    Robles-Vidal, C.
    Drucker-Zertuche, M.
    Cabrera-Galeana, P.
    Cantu-De Leon, D.
    CANCER RESEARCH, 2019, 79 (04)
  • [2] BREAST-Q Translation and Linguistic Validation to European Portuguese
    Meireles, Rita
    Tome, Goncalo
    Pinheiro, Susana
    Diogo, Carla
    ACTA MEDICA PORTUGUESA, 2022, 35 (11) : 823 - 829
  • [3] Translation and Linguistic Validation of the Mastectomy Module of the BREAST-Q Questionnaire for Use in Nigeria
    Olasehinde, Olalekan
    Romanoff, Anya
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (06)
  • [4] Clinical Validation of the BREAST-Q Breast-Conserving Therapy Module
    Stolpner, Ilona
    Heil, Joerg
    Feisst, Manuel
    Karsten, Maria Margarete
    Weber, Walter P.
    Blohmer, Jens-Uwe
    Forster, Tobias
    Golatta, Michael
    Schuetz, Florian
    Sohn, Christof
    Hennigs, Andre
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (09) : 2759 - 2767
  • [5] Development and Validation of the BREAST-Q Breast-Conserving Therapy Module
    Klassen, Anne F.
    Dominici, Laura
    Fuzesi, Sarah
    Cano, Stefan J.
    Atisha, Dunya
    Locklear, Tracie
    Gregorowitsch, Madelijn L.
    Tsangaris, Elena
    Morrow, Monica
    King, Tari
    Pusic, Andrea L.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (07) : 2238 - 2247
  • [6] Development and Validation of the BREAST-Q Breast-Conserving Therapy Module
    Anne F. Klassen
    Laura Dominici
    Sarah Fuzesi
    Stefan J. Cano
    Dunya Atisha
    Tracie Locklear
    Madelijn L. Gregorowitsch
    Elena Tsangaris
    Monica Morrow
    Tari King
    Andrea L. Pusic
    Annals of Surgical Oncology, 2020, 27 : 2238 - 2247
  • [7] Clinical Validation of the BREAST-Q Breast-Conserving Therapy Module
    Ilona Stolpner
    Jörg Heil
    Manuel Feißt
    Maria Margarete Karsten
    Walter P. Weber
    Jens-Uwe Blohmer
    Tobias Forster
    Michael Golatta
    Florian Schütz
    Christof Sohn
    André Hennigs
    Annals of Surgical Oncology, 2019, 26 : 2759 - 2767
  • [8] Brazilian version of the Breast-Q©-Breast-Conserving Therapy Module 2.0: Translation, cross-cultural adaptation, and reproducibility
    Schunck, Tatiane de Sousa
    Veiga, Daniela Francescato
    Cavagna, Felipe Andreotta
    Grisotto Jr, L. E.
    Sabino Neto, M.
    Ferreira, Lydia Masako
    BREAST JOURNAL, 2021, 27 (01): : 72 - 74
  • [9] Breast Cancer and Reconstruction: Normative Data for Interpreting the BREAST-Q
    Payne, Rachael M.
    Siotos, Charalampos
    Manahan, Michele A.
    Rosson, Gedge D.
    Cooney, Carisa M.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2018, 141 (01) : 180E - 181E
  • [10] Psychometric validation of the Danish BREAST-Q reconstruction module
    Willert, Cecilie Balslev
    Christensen, Karl Bang
    Bidstrup, Pernille Envold
    Mellemkjaer, Lene
    Gerdes, Anne-Marie Axo
    Holmich, Lisbet Rosenkrantz
    BREAST, 2025, 79